INTRODUCTION
HIV continues to be a major public health challenge in sub-Saharan Africa, where an estimated 22 million people are living with HIV. 1 In a population of 40 million in Kenya, 1.6 million people of all ages were living with HIV in 2012 and an estimated 98,000 of these had acquired HIV infection within the preceding year, making Kenya's HIV epidemic the fourth largest worldwide. 1, 2 For this reason, Kenya has been regarded globally as a priority country in sub-Saharan Africa to reverse the spread of HIV in the region.
To implement effective HIV programs, nationally representative data that reflect the country's current HIV epidemiology are required. Since 2003, HIV testing has been included in national household surveys, including the Kenya Demographic and Health Surveys (2003 and 2008-09 ) and the Kenya AIDS Indicator Survey (KAIS) in 2007. [3] [4] [5] These surveys estimated that HIV prevalence in adults ranged from 6.3% to 7.4%. Data from these surveys have provided a clearer understanding of the magnitude, distribution, and trends in HIV infection, as well as coverage of HIV treatment and prevention interventions to inform policies and programs to address the epidemic. 6 We conducted a second Kenya AIDS Indicator Survey (KAIS 2012) to estimate HIV incidence and prevalence, assess trends in HIV prevalence since 2007, and identify factors associated with HIV infection to inform programmatic and policy decisions to guide the national HIV response for the next five years in Kenya.
METHODS
KAIS 2012 was a cross-sectional household survey of persons aged 18 months to 64 years, conducted from October 2012 to February 2013. The methods of this survey are described in detail elsewhere. 7 The survey was designed to provide representative estimates of HIV prevalence among adults and adolescents aged 15 to 64 years at the national and regional level for the urban and rural populace. Among children aged 18 months to 14 years, the survey was powered to provide estimates of HIV prevalence at the national level only. Because of regional insecurity at the time of the survey, the North Eastern region was not sampled. For the purposes of this article, we restricted our analyses to adults and adolescents aged 15 to 64 years.
Data Collection Procedures
Interviewers conducted face-to-face interviews with eligible participants. Interviews collected information on individual demographic and behavioral characteristics. Interview data were entered directly into tablet computers (Mirus Innovations, Mississauga, Ontario, Canada). Participants provided venous blood for HIV testing, which was performed at a central laboratory in Nairobi. If venous blood could not be collected, a finger prick was used to collect a dried capillary blood spot sample for HIV testing. Participants were informed that they would not receive the results of their laboratory tests but were offered homebased HIV testing and counseling services using the national HIV testing algorithm 8 if they wished to learn their HIV status in the privacy of their homes.
Laboratory Methods
At the central laboratory, the same validated HIV testing algorithm that was used in KAIS 2007 was applied to KAIS 2012 blood samples. All specimens were initially screened with Vironostika HIV-1/2 UNIF II Plus O Enzyme Linked Immunoassay (bioMérieux, Marcy l'Etoile, France). Specimens that were reactive were then tested with the Murex HIV.1.2.O HIV Enzyme Immunoassay (DiaSorin, SpA, Saluggia, Italy) to confirm reactivity. Specimens with discrepant results were retested using the same algorithm. Twice discrepant results were resolved using polymerase chain reaction (Cobas Amplicor HIV-1 Monitor Test, version 1.5, Roche Molecular Diagnostics, Pleasanton, CA). HIV-positive dried blood spot specimens were tested for HIV RNA concentration using the Abbott M2000 Real-Time HIV-1 Assay (Abbott Laboratories, Abbott Park, IL) and recent HIV infection using the Limiting Antigen Avidity Enzyme Immunoassay (LAg-Avidity EIA) (Maxim Biomedical, Inc., Rockville, MD). Specimens with a normalized optical density value of 1.5 or lower on the LAg-Avidity EIA and (1) not virally suppressed (defined as HIV RNA concentration ,1000 copies/mL) or (2) did not report use of antiretroviral therapy (ART) for their HIV infection were classified as indicative of recent infection. The estimated mean duration of recent infection for the assay was 130 days (95% confidence interval [CI] 118 to 142).
Data Management
We merged interview and laboratory data to produce a final survey data set for analysis. Survey data were weighted to correct for unequal probability of selection and adjusted for interview and blood nonresponse to produce estimates that were representative of the population from which the KAIS 2012 sample was drawn. All data were analyzed using SAS version 9.3 (SAS Institute, Cary, NC).
Data Analysis
We conducted univariate analyses and present frequencies and weighted proportions with 95% CI. Statistical significance for cross-tabulations was assessed using the Rao-Scott x 2 test. We assessed whether there were changes in HIV prevalence between KAIS 2007 and KAIS 2012 by age, sex, residence, and geographic region. A z-test was used to test for differences in proportions between the 2 surveys, and we considered a P value , 0.05 to be statistically significant.
Using the PROC SURVEYLOGISTIC procedure, we conducted bivariate and multivariate analyses to identify correlates of undiagnosed HIV infection among persons who had ever had sex and report results as odds ratios (OR), adjusted odds ratios (AOR), and 95% CI. We selected undiagnosed HIV infection as our main outcome of interest to identify subpopulations that were at the highest risk of acquiring and transmitting HIV infection. Predictor variables included the following: age, education, marital status, region, residence, household wealth, risk perception, condom use, number of sexual partners, lifetime history of high-risk behavior, including injecting drugs, anal sex, and transactional sex, symptoms of sexually transmitted infection (STI), self-reported circumcision among men, and circumcision status of male partners reported by women. Variables associated with undiagnosed HIV infection at P value ,0.2 in bivariate analyses were tested in a multivariate model to identify factors that were independently associated with undiagnosed HIV infection. Variables that remained significantly associated with HIV infection at P value ,0.05 were retained in the final model.
To estimate the number of adults and adolescents aged 15-64 years living with HIV and number with recently acquired HIV infection, we applied non-normalized survey weights to our HIV outcome variable. Non-normalized weights were based on the 2012 projected population data derived from the 2009 Kenya Population and Housing Census. 2 Annualized HIV incidence was calculated using the World Health Organization's recommended formula for estimating assay-based HIV incidence. 9 The annual HIV transmission rate per 100 persons living with HIV was calculated by dividing the estimated HIV incidence by the estimated HIV prevalence and multiplying this value by 100. 
RESULTS

Eligibility and Characteristics of Study Population
Of the 16,383 persons eligible for the survey, 13,720 (83.7%) consented to an interview. Among the 13,720 individuals in the interview sample, 11,626 (84.7%) provided a blood sample, representing the serologic sample from which HIV prevalence was estimated. Compared with individuals in the interview sample, significantly higher proportions of individuals in the serologic sample were from rural residences (64.1% compared with 56.4%, P = 0.003), from North Rift region (14.2% compared with 1.0%, P , 0.001), had ever been widowed (6.1% compared with 5.5%, P = 0.002), and were women who had been pregnant in the past (78.8% compared with 73.5%, P , 0.001), respectively (Table 1 ). In addition, compared with persons in the interview sample, significantly higher proportions of persons in the serologic sample reported being sexually active in the past 12 months (72.3% compared with 68.1%, P = 0.003), perceived that their risk of HIV infection was great (5.0% compared with 3.3%, P = 0.005), had received their last HIV test more than 12 months preceding the survey (45.1% compared with 38.1%, P , 0.001), and self-reported HIV-positive status based on their HIV testing history (4.1% compared with 2.1%, P , 0.001), respectively.
Among the 11,626 participants in the serologic sample, 51.3% were women. The median age was 33 years (interquartile range, 25-43). Over half (52.7%) had completed secondary school education or higher. The majority (64.1%) resided in rural areas; 14.7% were from Nyanza, 14.3% from Eastern South, 14.2% from North Rift, 9.8% from Nairobi, and 1.1% from Eastern North regions. Over half (57.5%) were currently in married or cohabiting relationships.
Most (87.4%) reported having ever had sexual intercourse, and 72.3% reported sexual intercourse in the past 12 months. Among these, 11.5% reported 2 or more partners in the past 12 months. Eighty-five percent of participants reported no to low self-perceived risk of HIV infection. Anal sex was reported by 1.9%. Receiving money, gifts, and favors in exchange for sex was reported by 3.8%. In total, 17.8% of men reported ever giving money, gifts, or favors in exchange for sex. Symptoms of STI in the past 12 months, including genital sores and/or vaginal (women only), penile (men only), or anal discharge were reported by 5.8% (2.7% of men and 8.7% of women). Among women, 78.8% had ever been pregnant, and 6.2% were currently pregnant at the time of the survey. Ninety-one percent of men were circumcised, and 70.1% of women reported that their current male partner was circumcised.
HIV Prevalence and Incidence
HIV prevalence was 5.6% (95% CI: 4.9 to 6.3), and HIV incidence was 0.5% (95% CI: 0.2 to 0.9), corresponding to an annual HIV transmission rate of 8.9 per 100 HIV-infected persons. Regional differences in HIV prevalence were observed with the highest HIV prevalence noted in Nyanza region (15.1%, 95% CI: 11.4 to 18.8) and lowest in Eastern North region (2.1%, 95% CI: 1.0 to 3.2) ( Table 2 ). Women had significantly higher HIV prevalence than men (6.9% vs. 4.4%; P , 0.0001). HIV prevalence increased with age, peaking at age 35-39 years among women (12.3%, 95% CI: 9.4 to 15.2) and age 45-54 years among men (7.2%, 95% CI: 4.9 to 9.6) (data not shown). HIV prevalence was highest among persons who had been widowed (20.0%, 95% CI: 16.2 to 23.7), separated or divorced (10.9%, 95% CI: 8.4 to 13.4), or were married or cohabiting in a polygamous relationship (9.7%, 95% CI: 6.4 to 13.1).
Trends in HIV Prevalence, 2007-2012
HIV prevalence declined significantly from 7.2% (excluding North Eastern region) in 2007 to 5.6% in 2012 (P = 0.002; Fig. 1 ). Significant declines were observed for both men (5.5% in 2007 to 4.4% in 2012; P = 0.0310) and women (8.5% in 2007; 6.9% in 2012; P = 0.006) (data not shown). We observed differential changes in HIV prevalence across age groups. In 2007, HIV prevalence peaked among persons aged 30-34 years (11.9%; 95% CI: 10.0 to 13.5), while in 2012, HIV prevalence peaked among persons aged 45-49 years (9.8%, 95% CI: 7.1 to 12.5). HIV prevalence declined significantly for persons who were aged 15-34 years in 2007 and 2012 (P # 0.010) but remained unchanged among persons aged 35 years and older in the same time period.
In Table 3 , we describe trends in HIV prevalence between 2007 and 2012 for select age groups by sex, geographic location, and residence. Among persons aged 15-24 years, we observed significant declines in HIV Among women aged 25-34 years, significant declines were observed among those residing in Nairobi (14.0% to 6.6%; P = 0.002), Coast (11.6% to 4.1%; P = 0.005), and Rift Valley (11.2% to 4.0%; P = 0.003) regions and those residing in both rural (11.4% to 6.3%; P , 0.001) and urban (13.5% to 8. 
Factors Associated With Undiagnosed HIV Infection
Of the 10,097 persons who had ever had sex, 6.3% (95% CI: 5.3 to 7.1) were HIV infected (Table 2) ; 52.2% (95% CI: 46.5 to 57.8) of these had undiagnosed HIV infection (data not shown). We compared individuals with undiagnosed HIV infection with those who were HIV uninfected to assess factors associated with undiagnosed HIV infection. Among men, factors that were independently associated with increased odds of undiagnosed HIV infection were widowhood (AOR: 8.1, 95% CI: 1.9 to 34.6, P = 0.005) and using a condom with the last sexual partner in the past year (AOR: 3.3, 95% CI: 1.8 to 6.2, P , 0.001) ( Table 4 ). In contrast, men who were circumcised had significantly lower odds of undiagnosed HIV infection (AOR: 0.3, 95% CI: 0.1 to 0.5, P , 0.001). Among women, higher odds of undiagnosed HIV infection were associated with being aged 34-39 years (AOR: 4.5, 95% CI: 1.1 to 18.3, P = 0.037), separated or divorced (AOR: 2.3, 95% CI: 1.1 to 5.0, P = 0.033), residence in Nyanza region (AOR: 2.9, 95% CI: 1.4 to 6.0, P = 0.004), living in urban areas (AOR: 1.8, 95% CI: 1.1 to 2.7, P = 0.012), having a moderate self-perceived risk of HIV infection (AOR: 2.1, 95% CI: 1.3 to 3.5, P = 0.002), using a condom with the last sexual partner in the past year (AOR: 2.3, 95% CI: 1.2 to 4.2, P , 0.009), and reporting $ 4 lifetime number of sexual partners (AOR: 1.9, 95% CI: 1.1 to 3.4, P = 0.026).
DISCUSSION
This population-based survey provides an update on the status of the HIV epidemic in Kenya. HIV prevalence was 5.6% and HIV incidence was 0.5% among persons aged 15-64 years. This represents approximately 1,192,000 million (95% CI: 1,037,000 to 1,347,000) adults and adolescents living with HIV in 2012, 106,000 (95% CI 32,000 to 180,000) of whom had recently acquired their HIV infection within the preceding year. These results broadly corroborate the 2012 estimates Declining incidence is also supported by the observation that HIV prevalence reduced significantly among younger persons aged 15-34 years between 2007 and 2012 but remained unchanged among older persons aged 35 years and above.
Among persons aged 15-34 years, we observed differential trends in HIV prevalence across geographic regions and sex, providing important epidemiologic evidence on sub-populations where substantial reductions in HIV infection may be occurring. Among women, declining prevalence was observed for women aged 15-34 years in Nairobi and Coast regions, women aged 15-24 years in Eastern region, and women aged 25-34 years in Rift Valley region. Among men, declining prevalence was observed among men aged 15-34 years in Coast region. Of concern, we found a significant increase in HIV prevalence among middle-aged and older women (aged $35 years) residing in Central region.
Reductions in HIV prevalence on a population level is possible if there are marked declines in new HIV infections or high rates of HIV-related death in a population. If substantial, both scenarios on their own could result in a diminished pool of infected people in the population. Over the past 5 years, Kenya has experienced substantial progress in linking HIV-infected persons into HIV care and placing those that require ART on treatment. 12 Increased coverage of ART and high levels of viral suppression on ART have led to significant reductions in HIV mortality and HIV transmission risk, likely contributing to a possible decline in HIV incidence over the past 5 years. 1, 12 Still, over half of HIV-infected persons in the country remained undiagnosed by the year-end (2012), representing a major barrier to achieving even greater reductions in HIV transmission to eventually halt the spread of infection. 13 A critical component to reversing this trend will be to accelerate ART coverage in the country by prioritizing HIV testing in settings that will yield greater numbers of HIV-infected persons, facilitating their immediate linkages into HIV care services, and treating them promptly.
Our findings provide important insight on groups with increased risk of transmitting HIV to sexual partners, highlighting opportunities for targeted HIV prevention. Markers of high-risk sexual behaviors, including multiple sexual partners and perceived risk of HIV infection were associated with higher odds of undiagnosed HIV infection. Surprisingly, we found that persons who used a condom with their last sexual partner in the past 12 months had higher odds of undiagnosed HIV infection. This positive association may be a reflection of reluctance or denial in admitting to unprotected sex. Alternatively, it could suggest that persons who choose to use condoms with their sexual partners may already know that they are at high risk of HIV infection despite lack of awareness of their HIV infection. The use of condoms in this group is an encouraging finding for HIV-positive prevention strategies but raises the question as to whether current condom use campaigns are effective in reaching the general population with messages on the important benefits of correct and consistent condom use for HIV prevention.
Widowhood has been previously described as a factor associated with HIV infection in Kenya and other countries in sub-Saharan Africa although the factors that place widowed men at higher risk of HIV infection are not clear-cut. [14] [15] [16] [17] [18] Widowers whose spouses died of HIV disease may have been exposed to high viral load from their partners, which can occur during late-stage disease, 17 but it is also possible that widowed men were sources of infection for their spouses who died from the disease. Studies have also demonstrated that widowers are more likely to engage in high-risk sexual behavior after the death of their spouse and contribute to new HIV infections in the population. 15 In addition to widowhood, the link between HIV infection and divorce or separation in women sheds additional light on the vulnerability of women in the Kenyan HIV epidemic. Previous studies in sub-Saharan Africa have reported that the dissolution of marriage, through divorce or separation, is often the result of a female's HIV status within the couple relationship. HIV-infected women in serodiscordant relationships are more likely to be separated or divorced than HIVinfected men in serodiscordant relationships, reinforcing the gender disparities that exist around sexual norms in the African context. 18 Further exploration of the impact of serodiscordancy on marital outcomes and implications for the spread of HIV may help to understand how to appropriately strategize prevention, care, and treatment services for couples and formerly married individuals.
Male circumcision has been widely cited as a key pillar of HIV prevention that can significantly reduce new HIV infections in a population. [19] [20] [21] Because of an aggressive national strategy on male circumcision, which was implemented in 2008, Kenya has observed substantial increases in male circumcision over the past 5 years, increasing from 85.0% in 2007 to 91.2% in 2012. 11 Greatest increases were noted in the 4 priority regions for the national voluntary male medical circumcision program: Nairobi, Nyanza, Rift Valley, and Western regions. 11 However, coverage in traditionally noncircumcising communities, where regional HIV prevalence is highest, still remains far below the national target of 80% of adult men. 22 We found lower odds of HIV infection among circumcised men highlighting that the prevention benefits of this intervention will continue to play an important role in addressing the HIV epidemic in Kenya. Further scale-up of HIV prevention should aim for universal male circumcision accompanied with sexual risk reduction strategies for greater impact in the longer term.
Our results provided important information on geographic areas which require specialized attention for HIV prevention. Continued momentum is needed to address persistently high levels of HIV infection in Nyanza region. Moreover, the observed increases in HIV prevalence among middle-aged and older women in Central region, as well as elevated risk of HIV infection among women in urban residences, are areas which require more focused strategies. Our study had several limitations. Because this study was cross-sectional in design, we were unable to infer directionality of associations, such as the associations between HIV infection and condom use with last sexual partner, widowhood among men, and divorce or separation among women. Behaviors, circumcision status, and symptoms of STI were self-reported, and associations observed may have been impacted by social desirability bias. Selection bias may have been introduced by decisions to exclude North Eastern region from the sampling frame because of security concerns. The North Eastern region, however, is relatively sparsely populated and had an HIV prevalence of only 0.8% in KAIS 2007, 5 and we feel it is unlikely that excluding this region affected our results substantially. Differences in HIV prevalence between KAIS 2007 and KAIS 2012 could also reflect changes in composition of the sample between the two surveys. Compared with KAIS 2007, the sample in KAIS 2012 had significantly higher proportions of persons who were aged 25-34 years, never married or never cohabited, reported secondary education or higher and were from urban residences. 7 The demographic, behavioral, and biological differences observed among KAIS 2012 participants in the interview and serologic sample may have also contributed to either an underestimation or overestimation of HIV prevalence in 2012, limiting our ability to accurately interpret trends in HIV prevalence.
Despite these limitations, KAIS 2012 was a large representative study whose primary findings were based on biological samples obtained during the survey. We believe that evidence of decreasing HIV prevalence to be encouraging yet underscores the need to establish routine and standardized surveillance methods to monitor trends in recently acquired HIV infections and HIVrelated mortality for a clearer interpretation of the epidemiology of HIV in the country. Our data support that substantial interventions are needed to improve identification of HIVinfected persons to effectively reach those in need of ART for improved survival and continued reductions in transmission risks. Continued monitoring of the burden of HIV disease through enhanced surveillance and seeking to assess and respond to factors associated with undiagnosed HIV infection are central to an effective response to the HIV epidemic in Kenya.
